Red Arrow Therapeutics is founded in 2021, operates from its headquarter in 1 Broadway Cambridge, Massachusetts 02142, US. The company operates in the Business Services, Research & Development sector.
Red Arrow Therapeutics specializes in Developing pH-activated drug delivery systems, Immunotherapy research, Tumor microenvironment manipulation, and offers services including RA-001, pH-activated polymer micelle, and IL-12 immunotherapy.
Total Rounds
US$ 4.5M
Last Round
US$ 4.5M
Rounds
1